Johnson & Johnson Vaccine Sites Closed in the U.S

Johnson & Johnson's Covid-19 vaccine was the first single dose Covid-19 vaccine available in the United States, which was approved for emergency use in the United States in late February.

In the United States, several states have temporarily shut down Johnson & Johnson vaccine sites, as people suffered adverse reactions after taking the vaccine.

A total of 18 people in North Carolina reported side effects, while 11 people in Colorado reacted to the shot with symptoms ranging from dizziness, nausea and fainting, according to media reports, Xinhua news agency reported on Monday.

UK PM Boris Johnson Gets AstraZeneca COVID-19 Vaccine
UK Prime Minister Boris Johnson has received the first dose of the AstraZeneca vaccine against coronavirus. Johnson, 56, is trying to reassure the public that the AstraZeneca jab is safe.

‘Johnson & Johnson's Covid-19 vaccine was the first single dose Covid-19 vaccine available in the United States, which was approved for emergency use in the United States in late February.’

Georgia was the third US state to temporarily shut down a vaccine site following North Carolina and Colorado, after eight people suffered adverse reactions following vaccination.

According to local officials, one person was sent to a nearby hospital for evaluation before being released. The other seven were sent home after being monitored at the site.

The US Centers for Disease Control and Prevention (CDC) said its analysis "did not find any safety issues or reason for concern." The agency recommended that healthcare providers continue to administer the Johnson & Johnson vaccine.

Merck to Manufacture Johnson & Johnson's Covid-19 Vaccine
Johnson & Johnson and Merck will work together to expand the production of Johnson & Johnson's covid-19 vaccine. Merck is the 9th manufacturer to join the global network and this collaboration will deliver the Covid-19 vaccine worldwide.

Another problem facing Johnson & Johnson is vaccine distribution. The supply of Johnson & Johnson's Covid-19 vaccine is expected to drop by 85 per cent nationwide this week, after the company suffered production issues at a facility in Baltimore, Maryland, according to federal officials and data.

A manufacturing subcontractor in Baltimore mixed ingredients from the Covid-19 vaccines of Johnson & Johnson and AstraZeneca, delaying shipments of the Johnson & Johnson shot across the nation.

US Panel Endorses Johnson & Johnson COVID-19 Vaccine for Emergency Approval
A high powered US vaccine advisory panel endorsed mass use of a single dose Johnson & Johnson Covid-19 vaccine.

The plant is run by Emergent BioSolutions, a manufacturing partner to both Johnson & Johnson and AstraZeneca. Federal officials attributed the mistake to human error, which resulted in contamination of up to 15 million doses of Johnson & Johnson's vaccine.

Jeff Zients, the White House coronavirus coordinator, said Friday that the company is still working to address the production issues in Emergent BioSolutions, which is not certified yet by the US Food and Drug Administration (FDA).

Johnson & Johnson's Covid-19 Vaccine Recommended for Americans
Johnson & Johnson's Covid-19 vaccine is recommended for Americans who are 18 years of age and older, said the US Centers for Disease Control and Prevention (CDC).

Johnson & Johnson's Covid-19 vaccine was approved for emergency use in the United States in late February. It is the third Covid-19 vaccine that has received FDA's authorization, also the first single dose Covid-19 vaccine available in the United States.

As of Monday, about 189 million Covid-19 vaccine shots have been administered, while more than 237 million Covid-19 vaccine doses have been distributed across the country, according to data of the CDC.

Source-IANS